Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 7:01 PM ET

Date/Time Source News Release
08/21/2024 09:00 AM EDT Business Wire Propanc Biopharma's Peer Reviewed Articles for Proenzymes Cancer Treatment Generates "Unprecedented" Interest
08/14/2024 09:00 AM EDT Business Wire Propanc Biopharma Receives Notice of Allowance for "Proenzyme Composition" Patent in North America
07/17/2024 09:00 AM EDT Business Wire Propanc Biopharma's CSO Predicts PRP Could Solve Problem That Impacts Response Rate of Immune Checkpoint Inhibitors Treating Solid Tumors
06/25/2024 09:00 AM EDT Business Wire Propanc Biopharma Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office
04/16/2024 09:00 AM EDT Business Wire Propanc Biopharma Receives Certificate of Grant for "Composition of Proenzymes for Cancer Treatment" Patent from European Patent Office
04/08/2024 09:00 AM EDT Business Wire Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financing
01/16/2024 09:00 AM EST Business Wire Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office
12/18/2023 09:00 AM EST Business Wire Propanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunities
12/13/2023 09:00 AM EST Business Wire Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP
11/07/2023 09:00 AM EST Business Wire Propanc Biopharma Confirms PRP Enhances Chemosensitivity and Alters Tumor Microenvironment of Pancreatic Tumor Cells
Page

Additional News

As of May 13, 2025 • 7:01 PM ET

Date/Time Source News Release
04/07/2025 08:58 AM EDT SeekingAlpha IPO Roundup: Circle Internet Group, OMS Energy and more
02/27/2025 04:31 AM EST US Earnings Reports Expected earnings - Propanc Biopharma Inc
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Propanc Biopharma Inc
08/14/2024 09:20 AM EDT SeekingAlpha Propanc Biopharma gets notice of allowance for Proenzyme Composition patent
02/15/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 15th, 2024
02/15/2024 04:38 AM EST US Earnings Reports Expected earnings - Propanc Biopharma Inc
02/08/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 8th, 2024
02/08/2024 04:38 AM EST US Earnings Reports Expected earnings - Propanc Biopharma Inc
11/13/2023 06:00 AM EST US Earnings Reports Expected US Company Earnings on Monday, November 13th, 2023
11/13/2023 04:37 AM EST US Earnings Reports Expected earnings - Propanc Biopharma Inc
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.